| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Artivion, Inc. (AORT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. AORT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 831.9K | $28.42M | - | |
| Other | 193.8K | $6.62M | - | |
| VP | 156.1K | $5.33M | - | |
| Dir | 150.1K | $5.13M | - | |
| Dir | 149.9K | $5.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Holloway Jean F | SVP, General Counsel | Sale+OE | 12,787 | $45.09 | $576,501.98 | -3.8% | |
| Nov 13, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 3,482 | $45.86 | $159,677.56 | -2.4% | |
| Nov 13, 2025 | Davis John E | Chief Commercial Officer | Sell | 6,563 | $45.86 | $300,966.05 | -3.2% | |
| Nov 13, 2025 | MacKin James P | President &CEO | Sell | 34,210 | $45.86 | $1,568,802.18 | -4.1% | |
| Nov 13, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 5,761 | $45.86 | $264,187.94 | -3.4% | |
| Nov 13, 2025 | Stanton Marshall S. | SVP, Clinical &MD Affair | Sell | 4,993 | $45.86 | $228,968.99 | -8.1% | |
| Nov 11, 2025 | Holloway Jean F | SVP, General Counsel | Sale+OE | 12,960 | $45.82 | $593,872.24 | -3.7% | |
| Nov 10, 2025 | MacKin James P | President &CEO | Sell | 17,580 | $44.62 | $784,402.02 | -2.1% | |
| Nov 10, 2025 | Davis John E | Chief Commercial Officer | Sell | 3,373 | $44.62 | $150,499.89 | -1.6% | |
| Nov 10, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 1,789 | $44.62 | $79,823.39 | -1.2% |